<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265677</url>
  </required_header>
  <id_info>
    <org_study_id>1524392</org_study_id>
    <nct_id>NCT04265677</nct_id>
  </id_info>
  <brief_title>FamilyLink Family-Centered Rounds</brief_title>
  <official_title>FamilyLink Family-Centered Rounds Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be a pilot test of using FamilyLink software to bring parents of patients in
      the neonatal intensive care unit (NICU) virtually to the bedside during Family Centered
      Rounds.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CAHPS Communication with Parent Subscale</measure>
    <time_frame>Through study completion, approximately 3 months</time_frame>
    <description>19 questions from the Communication with Parent Subscale of the Consumer Assessment of Healthcare Providers and Systems Child Hospital Survey; specifically, we will report the following measures: Communication between you and your child's nurses (composite measure); Communication between you and your child's doctors (composite measure); Communication about your child's medicines (composite measure); Keeping you informed about your child's care (composite measure) Privacy when talking with doctors, nurses, and other providers (single-item measure); Preparing you and your child to leave the hospital (composite measure); Keeping you informed about your child's care in the Emergency Room (single-item measure). Higher scores are better; 0 (minimum) - 100 (maximum)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of adverse events</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Rates of adverse events reported by parents, providers, or nurses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Through study completion, approximately 3 months</time_frame>
    <description>Hospital length of stay of the patient measured in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breastmilk at discharge</measure>
    <time_frame>Through study completion, approximately 3 months</time_frame>
    <description>If the patient was receiving all, some or no breastmilk</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Family Centered Rounds</condition>
  <arm_group>
    <arm_group_label>Telemedicine FCR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients will be eligible to use telemedicine for Family Centered Rounds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>These patients will not be eligible to use telemedicine for Family Centered Rounds (standard of care)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine FCR</intervention_name>
    <description>Parents/guardians will be able to join family centered rounds using telemedicine (audio and visual)</description>
    <arm_group_label>Telemedicine FCR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Parents/guardians will not be able to join family centered rounds using telemedicine (audio and visual)</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to the Blue Team in the NICU aged 0-365 days

          -  Parents/guardians of patients admitted to the Blue Team in the NICU aged ≥ 18 years

          -  Medical team members (physicians, nurse practitioners, fellows, residents, medical
             students, nurses) of patients admitted to the Blue Team in the NICU aged ≥ 18 years

        Exclusion Criteria:

          -  Patients who are not discharged home from the NICU (e.g., transferred to another
             inpatient unit or another hospital)

          -  Parents/guardians of patients admitted to the Blue Team in the NICU who do not speak
             English, as a translator will not reliability be available to participate in rounds
             when the parent/guardian is not physically present

          -  Patients who have more than one admission to the Blue Team during our study period
             will only be included on their first admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California-Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 7, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

